Regulation and function of the human HSP90AA1 gene

Gene

Volumn 570, Issue 1, 2015, Pages 8-16

  Zuehlke, Abbey D ^a   Beebe, Kristin ^a   Neckers, Len ^a   Prince, Thomas ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Drug target; Gene ontology; Gene promoter; Heat shock element; Heat shock protein; Interactome; Molecular chaperone; Post translational modification; Stress response

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 ALPHA A1; HEAT SHOCK PROTEIN 90 INHIBITOR; UNCLASSIFIED DRUG; HSP90AA1 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; CELL STRESS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE ONTOLOGY; GENE STRUCTURE; GENETIC TRANSCRIPTION; HISTONE UBIQUITINATION; HUMAN; NEOPLASM; NITROSYLATION; NONHUMAN; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ACETYLATION; PROTEIN DEGRADATION; PROTEIN METHYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SUMOYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PROTEIN PROCESSING;

ANIMALS; GENE EXPRESSION; GENE EXPRESSION REGULATION; HSP90 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN INTERACTION MAPS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84937738207     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.06.018     Document Type: Review

References (101)

1. Ammirante M., Rosati A., Gentilella A., Festa M., Petrella A., Marzullo L., Pascale M., Belisario M.A., Leone A., Turco M.C. The activity of hsp90α promoter is regulated by NF-κB transcription factors. Oncogene 2008, 27:1175-1178.
2. Banerji U., O'Donnell A., Scurr M., Pacey S., Stapleton S., Asad Y., et al. Phase I pharmacokinetic and pharmacodynamic study of 17-allylamino, 17-demethoxygeldanamycin in patients with advanced malignancies. J. clin. oncol. Amer. Soc. Clin. Oncol. 2005, 23(18):4152-4161.
3. Banerji U., Walton M., Raynaud F., Grimshaw R., Kelland L., Valenti M., et al. Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. Clin. Cancer Res. 2005, 11(19 Pt 1):7023-7032.
4. Beebe K., Mollapour M., Scroggins B., Prodromou C., Xu W., Tokita M., Taldone T., Pullen L., Zierer B.K., Lee M.J., Trepel J., Buchner J., Bolon D., Chiosis G., Neckers L. Posttranslational modification and conformational state of heat shock protein 90 differentially affect binding of chemically diverse small molecule inhibitors. Oncotarget 2013, 4(7):1065-1074.
5. Blagg B.S., Kerr T.D. Hsp90 inhibitors: small molecules that transform the Hsp90 protein folding machinery into a catalyst for protein degradation. Med. Res. Rev. 2006 May, 26(3):310-338.
6. Bohonowych J.E., Hance M.W., Nolan K.D., Defee M., Parsons C.H., Isaacs J.S. Extracellular Hsp90 mediates an NF-kappaB dependent inflammatory stromal program: implications for the prostate tumor microenvironment. Prostate 2014, 74(4):395-407.
7. Buffart T.E., Carvalho B., van Grieken N.C., van Wieringen W.N., Tijssen M., Kranenbarg E.M., et al. Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer. Oncologist 2012, 17(5):653-662.
8. Carbon S., Ireland A., Mungall C.J., Shu S., Marshall B., Lewis S., et al. AmiGO: online access to ontology and annotation data. Bioinformatics 2009, 25(2):288-289.
9. Cerami E., Gao J., Dogrusoz U., Gross B.E., Sumer S.O., Aksoy B.A., Jacobsen A., Byrne C.J., Heuer M.L., Larsson E., Antipin Y., Reva B., Goldberg A.P., Sander C., Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May, 2(5):401-404.
10. Chen B., Piel W.H., Gui L., Bruford E., Monteiro A. The HSP90 family genes in the human genome: insights into their divergence and evolution. Genomics 2005, 86(6):627-637.
11. Chen X.S., Zhang Y., Wang J.S., Li X.Y., Cheng X.K., Zhang Y., Wu N.H., Shen Y.F. Diverse effects of Stat1 on the regulation of hsp90alpha gene under heat shock. J. Cell. Biochem. 2007, 102(4):1059-1066.
12. Cheng Q., Chang J.T., Geradts J., Neckers L.M., Haystead T., Spector N.L., Lyerly H.K. Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer. Breast Cancer Res. 2012, 14(2):R62.
13. Chiosis G., Tao H. Purine-scaffold Hsp90 inhibitors. IDrugs 2006, 9(11):778-782.
14. Ciocca D.R., Arrigo A.P., Calderwood S.K. Heat shock proteins and heat shock factor 1 in carcinogenesis and tumor development: an update. Arch. Toxicol. 2013, 87(1):19-48.
15. Cortez-Gonzalez C., Barrera-Chimal J., Ibarra-Sanchez M., Gilbert M., Gamba G., Zentella A., Flores M.E., Bobadilla N.A. Opposite effect of Hsp90alpha and Hsp90beta on eNOS ability to produce nitric oxide or superoxide anion in human embryonic kidney cells. Cell. Physiol. Biochem. 2010, 26:657-668.
16. Donnelly A., Blagg B.S. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Curr. Med. Chem. 2008, 15(26):2702-2717.
17. Eccles S.A., Massey A., Raynaud F.I., Sharp S.Y., Box G., Valenti M., et al. NVP-AUY922: a novel heat shock protein 90 inhibitor active against xenograft tumor growth, angiogenesis, and metastasis. Cancer Res. 2008, 68(8):2850-2860.
18. Echeverria P.C., Bernthaler A., Dupuis P., Mayer B., Picard D. An interaction network predicted from public data as a discovery tool: application to the Hsp90 molecular chaperone machine. PLoS ONE 2011, 6(10):e26044.
19. Euskirchen G.M., Rozowsky J.S., Wei C.L., Lee W.H., Zhang Z.D., Hartman S., Emanuelsson O., Stolc V., Weissman S., Gerstein M.B., Ruan Y., Snyder M. Mapping of transcription factor binding regions in mammalian cells by chip: comparison of array- and sequencing-based technologies. Genome Res. 2007, 17(6):898-909.
20. Eustace B.K., Sakurai T., Stewart J.K., Yimlamai D., Unger C., Zehetmeier C., et al. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness. Nat. Cell Biol. 2004, 6(6):507-514.
21. Falsone S.F., Gesslbauer B., Tirk F., Piccinini A.M., Kungl A.J. A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett. 2005, 579(28):6350-6354.
22. Finka A., Goloubinoff P. Proteomic data from human cell cultures refine mechanisms of chaperone-mediated protein homeostasis. Cell Stress Chaperones 2013, 18(10):591-605.
23. Gallegos R.M., Floor K., Roepman P., Rodriguez J.A., Meijer G.A., Mooi W.J., Jassem E., Niklinski J., Muley T., van Zandwijk N., Smit E.F., Beebe K., Neckers L., Yistra B., Giaccone G. Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target. PLoS ONE 2008, 3(3):e0001722.
24. Gano J.J., Simon J.A. A proteomic investigation of ligand-dependent HSP90 complexes reveals CHORDC1 as a novel ADP-dependent HSP90-interacting protein. Mol. Cell Proteomics 2010, 9(2):255-270.
25. Gao J., Aksoy B.A., Dogrusoz U., Dresdner G., Gross B., Sumer S.O., Sun Y., Jacobsen A., Sinha R., Larsson E., Cerami E., Sander C., Schultz N. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 2013 Apr 2, 6(269):1.
26. Garnier C., Lafitte D., Tsvetkov P.O., Barbier P., Leclerc-Devin J., Millot J.M., Briand C., Makarov A.A., Catelli M.G., Peyrot V. Binding of ATP to heat shock protein 90: evidence for an ATP-binding site in the C-terminal domain. J. Biol. Chem. 2002, 277(14):12208-12214.
27. Söti C., Rácz A., Csermely P. A nucleotide-dependent molecular switch controls ATP binding at the C-terminal domain of Hsp90. N-terminal nucleotide binding unmasks a C-terminal binding pocket. J. Biol. Chem. 2002 Mar 1, 277(9):7066-7075.
28. Gong Y., Kakihara Y., Krogan N., Greenblatt J., Emili A., Zhang Z., et al. An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell. Mol. Syst. Biol. 2009, 5:275.
29. Grad I., Cederroth C.R., Walicki J., Grey C., Barluenga S., Winssinger N., De Massy B., Nef S., Picard D. The molecular chaperon Hsp90alpha is required for meiotic progression of spermatocytes beyond pachytene in the mouse. PLoS ONE 2010, 5:e15770.
30. Grenert J.P., Sullivan W.P., Fadden P., Haystead T.A., Clark J., Mimnaugh E., et al. The amino-terminal domain of heat shock protein 90 (hsp90) that binds geldanamycin is an ATP/ADP switch domain that regulates hsp90 conformation. J. Biol. Chem. 1997, 272(38):23843-23850.
31. Gress T.M., Muller-Pillasch F., Weber C., Lerch M.M., Friess H., Buchler M., Beger H.G., Adler G. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Res. 1994, 54(2):547-551.
32. Gupta R.S. Phylogenetic analysis of the 90kD heat shock family of protein sequences and an examination of the relationship among animals, plants, and fungi species. Mol. Biol. Evol. 1995, 12(6):1062-1073.
33. Hacker S., Lambers C., Hoetzenecker K., Pollreisz A., Aigner C., Lichtenauer M., Mangold A., Niederpold T., Zimmermann M., Tghavi S., Klepetko W., Ankersmit H.J. Elevated Hsp27, Hsp70 and Hsp90 alpha in chronic obstructive pulmonary disease: markers for immune activation and tissue destruction. Clin. Lab. 2009, 55(1-2):31-40.
34. Hartson S.D., Matts R.L. Approaches for defining the Hsp90-dependent proteome. Biochim. Biophys. Acta 2012, 1823(3):656-667.
35. http://bioinfogp.cnb.csic.es/tools/venny/.
36. http://genome.ucsc.edu/.
37. http://www.ncbi.nlm.nih.gov/gene.
38. Hudson M.E., Snyder M. High-throughput methods of regulatory element discovery. Biotechniques 2006, 41(6):673. (675, 677).
39. Jameel A., Skilton R.A., Campbell T.A., Chander S.K., Coombes R.C., Lugmani Y.A. Clinical and biological significance of HSP89 alpha in human breast cancer. Int. J. Cancer 1992, 50(3):409-415.
40. Jego G., Hazoume A., Seigneuric R., Garrido C. Targeting heat shock proteins in cancer. Cancer Lett. 2013, 332(2):275-285.
41. Jhaveri K., Taldone T., Modi S., Chiosis G. Advances in the clinical development of heat shock protein 90 (Hsp90) inhibitors in cancers. Biochem. Biophys. Acta 2012, 1823(3):742-755.
42. Kajiwara C., Kondo S., Uda S., Dai L., Ichiyanagi T., Chiba T., et al. Spermatogenesis arrest caused by conditional deletion of Hsp90alpha in adult mice. Biol. open 2012, 1(10):977-982.
43. Kubota H., Yamamoto S., Itoh E., Abe Y., Nakamura A., Izumi Y., Okada H., Iida M., Nanjo H., Itoh H., Yamamoto Y. Increased expression of co-chaperone HOP and HSP90 and HSC70 and complex formation in human colonic carcinoma. Cell Stress Chaperones 2010, 15(6):1003-1011.
44. Kummar S., Gutierrez M.E., Gardner E.R., Chen X., Figg W.D., Zajac-Kaye M., et al. Phase I trial of 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), a heat shock protein inhibitor, administered twice weekly in patients with advanced malignancies. Eur. J. Cancer 2010, 46(2):340-347.
45. Kunisawa J., Shastri N. Hsp90alpha chaperones large C-terminally extended proteolytic intermediates in the MHC class I antigen processing pathway. Immunity 2006, 24:523-534.
46. Kurokawa M., Zhao C., Reya T., Kornbluth S. Inhibition of apoptosome formation by suppression of Hsp90beta phosphorylation in tyrosine-induced leukemias. Mol. Cell. Biol. 2008, 28:5494-5506.
47. Lancet J.E., Gojo I., Burton M., Quinn M., Tighe S.M., Kersey K., et al. Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemia. Leukemia 2010, 24(4):699-705.
48. Lees-Miller S.P., Anderson C.W. The human double-stranded DNA-activated protein kinase phosphorylates the 90-kDa heat shock protein, hsp90 alpha at two NH2-terminal threonine residues. J. Biol. Chem. 1989, 264:17275-17280.
49. Lei H., Venkatakrishnan A., Yu S., Kazluauskas A. Protein kinase A-dependent translocation of Hsp90 alpha impairs endothelial nitric-oxide synthase activity in high glucose and diabetes. J. Biol. Chem. 2007, 282:9364-9371.
50. Low J.S., Fassati A. Hsp90: a chaperone for HIV-1. Parasitology 2014, 141(9):1192-1202.
51. McCready J., Sims J.D., Chan D., Jay D. Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 2010, 10:294.
52. Metz K., Ezernieks J., Sebald W., Duschl A. Interleukin-4 upregulates the heat shock protein Hsp90alpha and enhances transcription of a reporter gene coupled to a single heat shock element. FEBS Lett. 1996, 385(1-2):25-28.
53. Mollapour M., Neckers L. Post-translational modifications of Hsp90 and their contributions to chaperone regulation. Biochim. Biophys. Acta 2012, 1823(3):648-655.
54. Mollapour M., Tsutsumi S., Neckers L. Hsp90 phosphorylation, Wee1 and the cell cycle. Cell Cycle 2010, 9(12):2310-2316.
55. Mollapour M., Tsutsumi S., Truman A.W., Xu W., Vaughan C.K., Beebe K., Konstantinova A., Vourganti S., Panaretou B., Piper P.W., Trepel J.B., Prodromou C., Pearl L.H., Neckers L. Threonine 22 phosphorylation attenuates Hsp90 interaction with cochaperones and affects its chaperone activity. Mol. Cell 2011, 41(6):627-681.
56. Moulick K., Ahn J.H., Zong H., Rodina A., Cerchietti L., Gomes DaGama E.M., Caldas-Lopes E., Beebe K., Perna F., Hatzi K., Vu L.P., Zhao X., Zatorska D., Taldone T., Smith-Jones P., Alpaugh M., Gross S.S., Pillarsetty N., Ku T., Lewis J.S., Larson S.M., Levine R., Erdjument-Bromage H., Guzman M.L., Nimer S.D., Melnick A., Neckers L., Chiosis G. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat. Chem. Biol. 2011, 7(11):818-826.
57. Muller P., Ruckova E., Halada P., Coates P.J., Hrstka R., Land D.P., Vojtesek B. C-terminal phosphorylation of Hsp70 and Hsp90 regulates alternate binding to co-chaperones CHIP and HOP to determine cellular protein folding/degradation balances. Oncogene 2013, 32:3101-3110.
58. Neckers L., Trepel J.B. Stressing the development of small molecules targeting HSP90. Clin. Cancer Res. 2014, 20(2):275-277.
59. Ozawa K., Murakami Y., Eki T., Soeda E., Yokoyama K. Mapping of the gene family for the human heat-shock protein 90 alpha to chromosomes 1, 4, 11, and 14. Genomics 1992, 12(2):214-220.
60. Pacey S., Wilson R.H., Walton M., Eatock M.M., Hardcastle A., Zetterlund A., et al. A phase I study of the heat shock protein 90 inhibitor alvespimycin (17-DMAG) given intravenously to patients with advanced solid tumors. Clin. Cancer Res. 2011, 17(6):1561-1570.
61. Patel H.J., Modi S., Chiosis G., Taldone T. Advances in the discovery and development of heat-shock protein 90 inhibitors for cancer treatment. Expert opin. drug discovery 2011, 6(5):559-587.
62. Perotti C., Liu R., Parusel C.T., Bocher N., Schultz J., Bork P., Pfitzner E., Groner B., Shemanko C.S. Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation. Breast Cancer Res. 2008, 10(6):R94.
63. Peterson L.B., Eskew J.D., Vielhauer G.A., Blagg B.S. The hERG channel is dependent upon the Hsp90alpha isoform for maturation and trafficking. Mol. Pharm. 2012, 9:1841-1846.
64. Picard D. Heat-shock protein 90, a chaperone for folding and regulation. Cell. Mol. Life Sci. 2002, 59(10):1640-1648.
65. Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 1997, 90(1):65-75.
66. Quanz M., Herbette A., Sayarath M., de Koning L., Dubois T., Sun J.S., Dutreix M. Heat shock protein 90α (Hsp90α) is phosphorylated in response to DNA damage and accumulates in repair foci. J. Biol. Chem. 2012, 287(12):8803-8815.
67. Rebbe N.G., Hickman W.S., Ley T.J., Stafford D.W., Hickman S. Nucleotide sequence and regulation of a human 90-kDa heat shock protein gene. J. Biol. Chem. 1989, 264(25):15006-15011.
68. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., Pearl L.H. Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin. J. Med. Chem. 1999, 42:260-266.
69. Rosenhagen M.C., Soti C., Schmidt U., Wochnik G.M., Hartl F.U., Holsboer F., Young J.C., Rein T. The heat shock protein 90-targeting drug cisplatin selectively inhibits steroid receptor activation. Mol. Endocrinol. 2003, 17(10):1991-2001.
70. Ruckova E., Muller P., Nenutil R., Voitesek B. Alterations of the Hsp70/Hsp90 chaperone and the HOP/CHIP co-chaperone system in cancer. Cell. Mol. Biol. Lett. 2012, 17(3):446-458.
71. Schulte T.W., Akinaga S., Soga S., Sullivan W., Stensgard B., Toft D., et al. Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin. Cell stress & chap 1998, 3(2):100-108.
72. Scroggins B.T., Robzyk K., Wang D., Marcu M.G., Tsutsumi S., Beebe K., et al. An acetylation site in the middle domain of Hsp90 regulates chaperone function. Mol. Cell 2007, 25(1):151-159.
73. Sharma S.V., Agatsuma T., Nakano H. Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 1998, 16(20):2639-2645.
74. Skarra D.V., Goudreault M., Choi H., Mullin M., Nesvizhskii A.I., Gingras A.C., et al. Label-free quantitative proteomics and SAINT analysis enable interactome mapping for the human Ser/Thr protein phosphatase 5. Proteomics 2011, 11(8):1508-1516.
75. Smith D.R., McCarthy S., Chrovian A., Olinger G., Stossel A., Geisbert T.W., Hensley L.E., Connor J.H. Inhibition of heat-shock protein 90 reduces Ebola virus replication. Antiviral Res. 2010, 87(2):187-194.
76. Solier S., Kohn K.W., Scroggins B., Xu W., Trepel J., Neckers L., et al. Heat shock protein 90alpha (HSP90alpha), a substrate and chaperone of DNA-PK necessary for the apoptotic response. Proc. Natl. Acad. 2012, 109(32):12866-12872.
77. Soti C., Vermes A., Haystead T.A., Csermely P. Comparative analysis of the ATP-binding sites of Hsp90 by nucleotide affinity cleavage: a distinct nucleotide specificity of the C-terminal ATP-binding site. Eur. J. Biochem. 2003, 270(11):2421-2428.
78. Sreedhar A.S., Kalmar E., Csermely P., Shen Y. Hsp90 isoforms: functions, expression and clinical importance. FEBS Lett. 2004, 1-3:11-15.
79. Stebbins C.E., Russo A.A., Schneider C., Rosen N., Hartl F.U., Pavletich N.P. Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 1997, 89(2):239-250.
80. Stravopodis D.J., Margaritis L.H., Voutsinas G.E. Drug-mediated targeted disruption of multiple protein activities through functional inhibition of the Hsp90 chaperone complex. Curr. Med. Chem. 2007, 14:3122-3138.
81. Taherian A., Krone P.H., Ovsenek N. A comparison of Hsp90alpha and Hsp90beta interactions with cochaperones and substrates. Biochem. Cell Biol. 2008, 86(1):37-45.
82. Taipale M., Jarosz D.F., Lindquist S. HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nature Rev. Mol. Cell Biol. 2010, 11:515-528.
83. Taipale M., Tucker G., Peng J., Krykbaeva I., Lin Z.Y., Larsen B., et al. A quantitative chaperone interaction network reveals the architecture of cellular protein homeostasis pathways. Cell 2014, 158(2):434-448.
84. Taldone T., Ochiana S.O., Patel P.D., Chiosis G. Selective targeting of the stress chaperome as a therapeutic strategy. Trends Pharmacol. Sci. 2014, 35(11):592-603.
85. Teng S.C., Chen Y.Y., Su Y.N., Chou P.C., Chiang Y.C., Tseng S.F., Wu K.J. Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. J. Biol. Chem. 2004, 279(15):14649-14655.
86. Tian W.L., He F., Fu X., Lin J.T., Tang P., Huang Y.M., Guo R., Sun L. High expression of heat shock protein 90 alpha and its significance in human acute leukemia cells. Gene 2014, 542(2):122-128.
87. Trepel J., Mollapour M., Giaccone G., Neckers L. Targeting the dynamic HSP90 complex in cancer. Nat. Rev. Cancer 2010, 10(8):537-549.
88. Tripathi V., Obermann W.M. A primate specific extra domain in the molecular chaperone Hsp90. PLoS ONE 2013, 8:e71856.
89. Ullrich S.J., Moore S.K., Appella E. Transcriptional and translational analysis of the murine 84- and 86-kDa heat shock proteins. J. Biol. Chem. 1989, 264(12):6810-6816.
90. Voss A.K., Thomas T., Gruss P. Mice lacking HSP90beta fail to develop a placental labyrinth. Development 2000, 127(1):1-11.
91. Wang X., Song X., Zhou W., Fu Y., Shi H., Liang Y., Tong M., Chang G., Luo Y. The regulatory mechanism of Hsp90 {alpha} secretion and its function in tumor malignancy. Proc. Natl. Acad. Sci. U. S. A. 2009.
92. Wang J., Chen B., Wang Y., Wang N., Garbey M., Tran-Son-Tay R., Berceli S.A., Wu R. Reconstructing regulatory networks from dynamic plasticity of gene expression by mutual information. Nucleic Acids Res. 2013, 41(8):e97.
93. Whitesell L., Lindquist S.L. HSP90 and the chaperoning of cancer. Nat. Rev. Cancer 2005, 5(10):761-772.
94. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., Neckers L.M. Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. PNAS 1994, 91(18):8324-8328.
95. Workman P., Burrows F., Neckers L., Rosen N. Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress. Ann. N. Y. Acad. Sci. 2007, 1113:202-216.
96. Xu W., Mollapour M., Prodromou C., Wang S., Scroggins B.T., Palchick Z., Beebe K., Siderius M., Lee M.J., Couvillon A., Trepel J.B., Miyata Y., Matts R., Neckers L. Dynamic tyrosine phosphorylation modulates cycling of the Hsp90-P50(CDC37)-AHA1 chaperone machine. Mol. Cell 2012, 47(3):434-443.
97. Yang Y., Rehka R., Shen J., Tang Y., Fiskus W., Nechtman J., Atadja P., Bhalla K. Role of acetylation and extracellular location of heat shock protein 90α in tumor cell invasion. Cancer Res. 2008, 68:4833.
98. Yufu Y., Nishimura J., Nawata H. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leuk. Res. 1992, 16(6-7):597-605.
99. Zhang S., Yu J., Cheng X., Ding L., Heng F., Wu N., Shen Y. Regulation of human Hsp90α gene expression. FEBS Lett. 1999, 444:130-135.
100. Zhao Y., Gilmore R., Leone G., Coffey M.C., Weber B., Lee P.W.K. Hsp90 phosphorylation is linked to its chaperoning function assembly of the reovirus cell attachment protein. J. Biol. Chem. 2001, 276:32822-32827.
101. Zhao R., Davey M., Hsu Y.C., Kaplanek P., Tong A., Parsons A.B., et al. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the hsp90 chaperone. Cell 2005, 120(5):715-727.